Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net income (loss)	$ 2,941,425	$ (8,168,814)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	522	1,347
Impairment expense		4,934,429
Amortization of debt discount	723,688	780,514
Common stock issued for professional fees	1,000
Series D preferred stock issued for compensation	15,000
(Gain) loss on change in derivative liabilities	(4,624,168)	1,417,783
Gain on disposition of subsidiary	(316,985)
Warrants issued for professional fees		188,127
Bad debt expense	356,851
Changes in operating assets and liabilities:
Prepaid expenses	(808)	(2)
Accounts payable	13,042	668
Accrued expenses and other current liabilities	1,141	180
Accrued interest - notes payable	250,492	188,313
Change in net assets of discontinued operations	10,843	(39,274)
Net cash used in operating activities	(627,957)	(696,729)
Cash flows from investing activities:
Cash flows from financing activities:
Proceeds from convertible notes payable	617,000	692,500
Net cash provided by financing activities	617,000	692,500
Net decrease in cash	(10,957)	(4,229)
Cash, beginning of period	19,232	23,461
Cash, end of period	8,275	19,232
Supplemental disclosure:
Cash paid for income taxes
Cash paid for interest		304
Non-cash financing and investing activities:
Debt discount for derivative liabilities	$ 617,000	$ 692,500
Common shares issued in conversion of debt	389,923	11,170
Redemption of Series C preferred stock	$ 36
Operating lease right to use asset	18,352
Series C preferred shares issued in merger		4,345,866
Stock options issued in merger		599,998
Redemption of Series A preferred stock		$ 1